Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + Exemestane + OFS in Premenopausal ER+/HER2- MBC
NCT02917005Phase 2Unknown
- Start
- May 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer. Status: unknown.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02917005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02917005.